Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:1384
SEHK:1384Software

Deepexi Technology (SEHK:1384) EPS Loss Narrows In 1H 2025 Testing Bearish Narratives

Deepexi Technology (SEHK:1384) has reported fresh numbers for FY 2025, with first half revenue of C¥132.1 million and a basic EPS loss of C¥1.12, while the trailing twelve months show revenue of C¥314.5 million and a basic EPS loss of C¥3.92. The company’s revenue moved from C¥129.0 million in 2H 2023 to C¥242.9 million in 2H 2024 and then to C¥132.1 million in 1H 2025. Net income excluding extra items shifted from a loss of C¥502.9 million in 2H 2023 to a loss of C¥1.25 billion in 2H 2024...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

A Look At Merit Medical Systems (MMSI) Valuation After The Recent Share Price Pullback

Event context and recent share performance Merit Medical Systems (MMSI) shares have come under pressure recently, with the stock showing a 2.4% decline over the past day, 4.6% over the past week, and deeper pullbacks over the past month and past 3 months. See our latest analysis for Merit Medical Systems. The recent pullback, including a 30 day share price return of 18.9% decline and a year to date share price return of 22.8% decline, sits alongside a 1 year total shareholder return of 34.4%...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Opera Deepens Celo Ties As MiniPay And Valuation Story Converge

Opera (NasdaqGS:OPRA) and Celo have agreed a restructured, multi year partnership that makes Opera a major network stakeholder in the Celo ecosystem. The deal centers on MiniPay and a planned push to drive global stablecoin usage across up to 50 million Opera users. The partnership includes a 160 million CELO allocation, expansion of MiniPay into new markets, and grassroots roadshows to support user adoption. Opera, trading at $14.36, now ties a bigger part of its fintech plans to the Celo...
NYSE:HESM
NYSE:HESMOil and Gas

Is It Too Late To Consider Hess Midstream (HESM) After Strong Multi‑Year Returns?

Wondering if Hess Midstream at around US$39.59 is still offering value, or if most of the easy gains are already on the table. The stock has returned 1.5% over the last 7 days, 4.5% over the last 30 days, 14.3% year to date and 0.4% over the past year, with very large returns over the past 3 and 5 years of 85.1% and 173.4% respectively. Recent coverage has focused on Hess Midstream's role as a midstream infrastructure provider and how that positions the company within the broader energy...
NasdaqGS:IOSP
NasdaqGS:IOSPChemicals

Is Innospec (IOSP) Now At An Attractive Price After Recent Share Price Slide

Wondering if Innospec, at around its recent US$65.89 close, is offering value or a value trap? This review breaks down what the current share price really reflects. The stock has recently seen a 4% decline over the past week, an 18.9% decline over the past month, and a 29.9% decline over the last year, which may signal that the market is reassessing both growth potential and risk. Recent coverage of Innospec has focused on its position within the chemicals sector and how investors are...
NYSE:TRU
NYSE:TRUProfessional Services

TransUnion Machine Learning Fraud Tools Tested Against Weak Share Price Momentum

TransUnion (NYSE:TRU) has rolled out new machine learning capabilities within its Device Risk fraud prevention solution. The update targets recent surges in digital fraud and suspected account takeovers, aiming to improve detection accuracy and reduce manual review work for clients. The company is highlighting adaptive, consortium driven risk scoring as a way to respond to more complex fraud patterns in digital channels. TransUnion enters this product update phase with its shares at $70.55...
XTRA:FPE3
XTRA:FPE3Chemicals

Fuchs (XTRA:FPE3) Higher 8.6% Net Margin Tests Concerns Over Slower Revenue Growth

Fuchs (XTRA:FPE3) FY 2025 earnings snapshot Fuchs (XTRA:FPE3) has wrapped up FY 2025 with fourth quarter revenue of €863 million and net income of €78 million, while trailing twelve month revenue came in at €3.6 billion and net income at €306 million, framing a steady earnings picture. Over the past few quarters, the company has seen quarterly revenue move between €859 million and €924 million, with quarterly net income ranging from €67 million to €84 million. This gives a clear sense of how...
ASX:PME
ASX:PMEHealthcare Services

A Look At Pro Medicus (ASX:PME) Valuation After Recent Senior Leadership Changes

Pro Medicus (ASX:PME) has reshaped its senior leadership, with long-serving CFO Clayton Hatch moving into combined Head of Business Operations and Head of Investor Relations roles, while Danny English steps up as the new Chief Financial Officer. See our latest analysis for Pro Medicus. These leadership changes come as Pro Medicus trades at A$120.06, with a 1 day share price return of negative 2.09% and a year to date share price return of negative 46.07%. The 5 year total shareholder return...
NasdaqCM:LIDR
NasdaqCM:LIDRElectronic

Is AEye (LIDR) Using NVIDIA Lab Access To Recast Its Safety Tech Narrative Despite Losses?

In March 2026, AEye, Inc. announced it had joined the ANAB-accredited NVIDIA Halos AI Systems Inspection Lab to collaborate on validating safety, cybersecurity, and system integration of its Apollo, STRATOS, and OPTIS lidar solutions with NVIDIA DRIVE platforms. On the same day, AEye reported fourth-quarter 2025 sales of US$97,000 and a net loss of US$7.34 million, with full-year 2025 sales of US$233,000 and a net loss of US$33.96 million, showing modest revenue progress alongside continued...
TSE:6586
TSE:6586Machinery

Is It Time To Reassess Makita (TSE:6586) After Recent Share Price Weakness?

If you are wondering whether Makita's current share price reflects its real worth, the starting point is to look closely at how the stock has actually behaved and what that might imply about value. Makita last closed at ¥5,236, with a 1.2% decline over the past week and a 12.9% decline over the past month, yet the stock is still up 9.4% year to date and 68.1% over three years. That mix of shorter term weakness and longer term gains means recent news and sentiment are important for...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics Credit Deal And Valuation Gap Catch Investor Attention

TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital. The agreement is described as non dilutive, meaning it does not involve issuing new equity to raise capital. The facility includes repayment of prior debt and could expand to as much as $1b in total available financing. TG Therapeutics focuses on developing and commercializing therapies in the biopharmaceutical space, where access to sizeable, flexible capital...
NasdaqGS:PRGS
NasdaqGS:PRGSSoftware

Is There Now An Opportunity In Progress Software (PRGS) After A 42% One Year Pullback?

Investors may be wondering whether Progress Software's current share price reflects its true value, or if the recent weakness is opening up an opportunity. The stock closed at US$31.29, with returns of an 8.8% decline over 7 days, a 22.4% decline over 30 days, a 23.8% decline year to date, and a 42.5% decline over 1 year. These moves may have shifted how the market views its risk and reward trade off. Recent headlines have focused on Progress Software's role as a software provider and how...
NYSE:RES
NYSE:RESEnergy Services

Is RPC (RES) Fairly Priced After Its Strong Multi Year Share Price Performance

If you are wondering whether RPC at US$6.83 is priced attractively or not, the starting point is understanding what the current market price might be implying about its future. Over the short term, the stock has returned 4.8% in the last 7 days, 12.0% over 30 days, 23.5% year to date, 28.6% over 1 year, and 38.1% over 5 years, while the 3 year return sits at a 4.0% decline. Recent coverage around RPC has focused on how investors are reassessing energy service providers, with attention on...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Jack Henry Award Win Highlights Small Business Payments Opportunity With Tap2Local

Jack Henry & Associates (NasdaqGS:JKHY) received the “Small Business Payments Solution of the Year” award at the FinTech Breakthrough Awards for its Tap2Local product. The recognition focuses on Tap2Local, a cloud-native payments solution designed for small business clients of banks and credit unions. For investors watching NasdaqGS:JKHY, this award offers insight into how the company is positioning itself within digital payments for community and regional financial institutions. Tap2Local...
XTRA:KRN
XTRA:KRNMachinery

Krones (XTRA:KRN) Margin Improvement To 5.2% Tests Bullish Expansion Narrative

Recent Earnings Snapshot Krones (XTRA:KRN) has opened FY 2025 with steady top and bottom line figures, with third quarter revenue at about €1.4b and basic EPS of €2.15, set against trailing 12 month EPS of €9.17 on revenue of roughly €5.6b and earnings growth of 16.1% over the past year. The company has seen quarterly revenue fluctuate in a relatively tight band between €1.3b and €1.4b since early 2024, while basic EPS has ranged from €2.08 to €2.40 over the same period, feeding into a...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Is Waystar Holding (WAY) Attractive After A 36% One Year Share Price Decline?

To understand whether Waystar Holding at US$24.07 offers value or just looks cheap on the surface, you need to weigh the recent share performance against the fundamentals. Over the last week the stock returned 0.4% lower, over the last month it is 6.7% lower, and over the year it is 23.3% lower year to date and 35.8% lower over 1 year, which may signal that expectations and risk perceptions have shifted. Recent coverage has focused on Waystar Holding's position in healthcare services and...
ENXTBR:094426466
ENXTBR:094426466Metals and Mining

SCR Sibelco (ENXTBR:094426466) Margin Compression Challenges Bullish Earnings Narratives

SCR-Sibelco (ENXTBR:094426466) has put fresh numbers on the table for FY 2025, reporting first half revenue of €1.2b and net income of €78.1m, while trailing 12 month revenue is €2.3b against net income of €63.4m. Over the past year, revenue has moved from €1.1b in the first half of 2024 and €1.1b in the second half of 2024 to €1.2b in the first half of 2025. Net income shifted from €145.9m to a loss of €14.7m and then to €78.1m over the same periods. For investors, the key storyline is how...
NasdaqGS:STBA
NasdaqGS:STBABanks

Is Slowing Net Interest Income And EPS Compression Altering The Investment Case For S&T Bancorp (STBA)?

In recent analyses, S&T Bancorp’s net interest income was found to have grown more slowly than the broader banking industry over the past five years and is now expected by sell-side analysts to decline by 5.3% in the coming 12 months, while earnings per share have fallen by 3.3% annually over the last two years on flat revenue. This combination of slowing core lending income and shrinking earnings, despite stable top-line performance, highlights ongoing pressure on the bank’s profitability...
NYSE:RYZ
NYSE:RYZMetals and Mining

A Look At Ryerson Holding (RYZ) Valuation After Recent Share Price Weakness

Ryerson Holding (RYZ) has drawn investor attention after a period of weaker share performance, with the stock down over the past month and past 3 months despite its sizeable US metals processing footprint. See our latest analysis for Ryerson Holding. The 30 day share price return of 28.71% and 90 day return of 23.69% point to fading momentum. Meanwhile, the 1 year total shareholder return of 10.06% contrasts with a weaker 3 year total shareholder return of 37.54%, suggesting investors are...
TSX:BOS
TSX:BOSChemicals

AirBoss Of America (TSX:BOS) Q4 Losses Keep Turnaround Narratives Under Pressure

AirBoss of America (TSX:BOS) closed out FY 2025 with Q4 revenue of US$106.0 million and a basic EPS loss of US$0.29, while net income excluding extra items came in at a loss of US$7.6 million, and on a trailing twelve month basis, revenue was US$410.2 million against a net loss of US$8.6 million and EPS of US$0.32 in the red. Over recent quarters, the company has seen quarterly revenue move between US$91.9 million and US$106.0 million, with basic EPS swinging from a profit of US$0.08 in Q2...
TSX:AAUC
TSX:AAUCMetals and Mining

Allied Gold Holders Weigh Zijin Cash Offer As Vote Nears

Independent proxy advisors ISS and Glass Lewis have recommended that Allied Gold shareholders vote in favour of Zijin Gold International's proposed acquisition. The Allied Gold Board is unanimously backing the deal ahead of the shareholder vote scheduled for 31 March 2026. The outcome of the vote will determine future control and direction of Allied Gold, which trades on the TSX under ticker TSX:AAUC. Allied Gold, trading at around CA$42.7 per share, has drawn increased attention after a...
TSX:NGD
TSX:NGDMetals and Mining

Is It Time To Reassess New Gold (TSX:NGD) After The Recent Share Price Pullback

Investors may be wondering whether New Gold's current share price still offers value after a strong run, or if most of the opportunity is already reflected in the market. The stock recently pulled back, with a 14.6% decline over the last week and a 15.3% decline over the past month, even though the 1 year return sits at 161.4% and the year to date return is 5.9%. This combination of sharp short term weakness and very strong longer term gains has put New Gold back on the radar for investors...
TSX:CDR
TSX:CDROil and Gas

Condor Energies Loss Reduction Trend Tests Bullish Valuation Narrative After FY 2025 Results

Condor Energies (TSX:CDR) has reported its FY 2025 numbers with Q4 total revenue of C$17.6 million and a basic EPS loss of C$0.03, alongside trailing twelve month revenue of C$69.5 million and a basic EPS loss of C$0.06. Over recent quarters, the company has seen quarterly revenue range from C$16.2 million to C$19.2 million, while basic EPS has stayed in loss making territory between C$0.00 and C$0.06, keeping the focus firmly on how efficiently each dollar of sales is being converted into...
SEHK:9886
SEHK:9886Consumer Retailing

Dingdang Health Technology Group (SEHK:9886) Loss Narrows To C¥51.7m Challenging Bearish Narratives

Dingdang Health Technology Group (SEHK:9886) has posted its FY 2025 first half results with revenue of C¥2.3b, a basic EPS loss of C¥0.04 per share and net income loss of C¥51.7m, keeping the focus firmly on the path toward breakeven. Over the recent reporting periods, revenue has moved from C¥2.27b in 1H 2024 to C¥2.40b in 2H 2024 and C¥2.33b in 1H 2025, while basic EPS losses have shifted from C¥0.06 in 1H 2024 to C¥0.22 in 2H 2024 and C¥0.04 in 1H 2025. This sets up an earnings season...